Structural Heart Imaging Market Report Scope & Overview:

The structural heart imaging market size was valued at USD 9.54 billion in 2024 and is expected to reach USD 15.09 billion by 2032, growing at a CAGR of 6.04% over the forecast period of 2025-2032.

The global structural heart imaging market is also driven by the growing global aging population, which is leading to an increase in the incidence of structural heart diseases that require enhanced imaging support. Moreover, increasing uptake of such minimally invasive and transcatheter procedures as TAVR and MitraClip a significant contributor, since these rely heavily on high-resolution imaging. This is indicative of a strong structural heart imaging market trend towards non-invasive, precision-directed cardiac procedures, thereby pushing market growth.

For instance, in February 2025, global structural heart imaging utilization among patients aged 65+ rose 22%, driven by increasing age-related heart disorders.

Key Structural Heart Imaging Market Trends

• Advanced imaging for accurate structural heart assessment and procedural planning.

• Enhances diagnostic accuracy, workflow efficiency, and predictive analytics in structural heart imaging.

• Imaging is critical for TAVR, MitraClip, and other catheter-based interventions.

• Higher prevalence of valvular and structural heart diseases among the elderly drives imaging demand.

• Rising cardiovascular care facilities in Asia-Pacific and Latin America.

• Trend toward safer, high-resolution, patient-friendly structural heart diagnostics.

Structural Heart Imaging Market Report Highlights

The U.S. structural heart imaging market was valued at USD 3.12 billion in 2024 and is expected to reach USD 4.89 billion by 2032, growing at a CAGR of 5.80% over 2025-2032. The US is highly focused on research and clinical trials and is a market leader in structural heart therapies in the Structural Heart Imaging Market. An increasing number of trials necessitating high-quality imaging for diagnosis, pre-intervention planning, and follow-up are driving the uptake of the technology. This dynamic is brought into focus in this new structural heart imaging market analysis as one of the factors supporting market leadership and innovation in Spain.

The global structural heart imaging market is projected to register high demand during the forecast period, owing to increasing incidence of cardiovascular diseases and structural heart diseases, the growing adoption of 3D/4D echocardiography, cardiac CT, and AI-based imaging and the rising preference for minimally invasive and transcatheter procedures, among others, as a result of continuous technological advances and the increasing healthcare infrastructure globally.

Key Structural Heart Imaging Market Segment Analysis

• By Modality, angiogram held the largest share of around 37.82% in 2024, and the CT segment is expected to register the highest growth with a CAGR of 7.03%.

• By Application, the interventional cardiology segment dominated the market with approximately 71.17% share in 2024, and is expected to register the highest growth with a CAGR of 6.19%.

• By Procedure, transcatheter aortic valve replacement (TAVR) accounted for the leading share of nearly 32.88% in 2024, whereas transcatheter mitral valve repair (TMVR) is expected to register the highest growth with a CAGR of 6.74%.

• By End User, the hospitals & clinics segment led the market with about 52.88% share in 2024, while the ambulatory surgical centers segment is forecasted to grow the fastest at a CAGR of 6.51%.

By Modality, Angiogram Lead Market and CT Register Fastest Growth

In 2024, the angiogram segment held a demanding revenue of around 37.82% in the structural heart imaging market share and is expected to continue its dominance, due to high accuracy in visualization of coronary and structural heart diseases, common use in pre- and post-procedures, and being preferred by cardiologists for assistance in non-invasive and transcatheter interventions. The CT segment is projected to experience the fastest CAGR growth of around 7.03%, driven by high-resolution imaging, fast scan times, non-invasive feasibility, and growing use for transcatheter applications for precise diagnosis and procedural planning.

By Application, Interventional Cardiology Dominates and Shows Rapid Growth Over the Forecast Period

The structural heart imaging industry was dominated by the interventional cardiology segment with a revenue share of over 71.17% in 2024, as it depends on accurate imaging for its minimally invasive procedures, including TAVR and MitraClip, supporting accurate diagnosis, procedural planning, and real-time guidance that leads to more structural heart imaging technologies. On the other hand, it is anticipated to record the fastest CAGR of 6.19% during the forecast period (2024-2032), due to the growing number of minimally invasive procedures, increasing prevalence of cardiovascular diseases, and technological advancements in imaging for accurate diagnosis and treatment.

By Procedure, TAVR Lead, Whereas TMVR Registers the Fastest Growth

The TAVR segment led the structural heart imaging industry with the highest revenue market share of about 32.88% in 2024, owing to the increasing preference for less invasive aortic valve procedures, reliance on high-resolution imaging for pre-procedural preparation, intra-procedural guidance, and post-procedural assessment, promoting its widespread utilization. The TMVR segment is likely to register the fastest CAGR of approximately 6.74% over the forecast years 2024-2032, driven by the increasing prevalence of mitral valve disease, rising adoption of minimally invasive procedures, and the growing dependence of valvuloplasty and valvulotomy on imaging for precise placement and guidance.

By End User, Hospitals & Clinics Lead, While Ambulatory Surgical Centers Grow the Fastest

The hospitals & clinics segment of the structural heart imaging industry was estimated as the highest earning segment with a revenue share of around 52.88% in 2024, owing to their high level of infrastructural support, access to premium imaging facilities and expertise in interventional cardiology, along with high patient numbers accessing broad scope of services including diagnostic assessment, procedural planning, and follow-up related to structural heart interventions. The ambulatory surgical centers segment is projected to attain the highest CAGR of approximately 6.51% throughout the forecast period (2024-2032), fueled by the rising number of minimally invasive procedures, economical imaging services, patient preference for outpatient care, and growing ASC infrastructure globally.

Asia Pacific Structural Heart Imaging Market Insights

The Asia Pacific segment is projected to witness the fastest CAGR of 6.84% during the forecast period of 2024–2032, owing to the increasing incidence of cardiovascular and structural heart diseases, the growing geriatric population, and the rise in healthcare infrastructure. Moreover, increasing consciousness, early diagnosis-related government efforts by the governing body, a surge in acceptance of technologically advanced imaging techniques, including 4D/3D echocardiography & cardiac CT, and growing minimally invasive techniques are expected to drive the market across China, India, and Japan.

North America Structural Heart Imaging Market Insights

North America accounted for the highest revenue share of approximately 38.76% in 2024 of the Structural Heart Imaging Market, driven by its strong medical infrastructure, high incidence of cardiovascular and structural heart diseases, and early applications of modern imaging modalities, e.g., 3D/4D echocardiography, cardiac CT, and artificial intelligence (AI) driven imaging. Furthermore, the area’s favorable reimbursement scenario, increase in adoption of minimally invasive and transcatheter surgeries, high prevalence rates, and strong clinical research activity make it the most advanced and largest market for cardiac surgeries.

Europe Structural Heart Imaging Market Insights

The Europe structural heart imaging market is growing steadily due to the aging of the population is a key factor that has enabled Europe to hold a leading position in the structural heart imaging market. Furthermore, tight regulatory standards lead to high-quality imaging adoption, and public–private partnerships in healthcare have resulted in the deployment of advanced diagnostic technology in hospitals and cardiac centers.

Latin America (LATAM) and Middle East & Africa (MEA) Structural Heart Imaging Market Insights

The Middle East & Africa and Latin America markets are also increasing, owing to increasing incidence rates of cardiovascular diseases, a rise in the geriatric population, and an increase in health awareness. The market growth is driven by the expansion of advanced cardiac care centers, rising acceptance of minimally invasive procedures, and the development of new imaging infrastructure. Government programs and collaborations with private companies are further increasing the accessibility of 3D/4D echocardiography, cardiac CT, and MRI technology in these regions.

Structural Heart Imaging Market Growth Drivers:

• Increasing Healthcare Infrastructure in Emerging Markets is Driving the Structural Heart Imaging Market Growth

Rise in awareness of animal health is also one of the key factors for the growth of the Structural Heart Imaging Market. Growth in pet owners’ concern regarding healthy nutrition, weight monitoring, and pets' well-being is driving the demand for automated feeders. With accurate portion control, purring schedules, and any monitoring, they are designed to allow owners to take care of their pets' health and obesity while also sharing their diets.

For instance, in January 2025, Global 3D/4D echocardiography usage in structural heart imaging grew 15% in 2024, reflecting advanced technology adoption and improved diagnostics.

Structural Heart Imaging Market Restraints:

• Skilled Personnel Requirement is Hampering the Structural Heart Imaging Market Growth

The complex knowledge and technical skills needed to run and interpret structural heart imaging systems (3D/4D echocardiography, cardiac computed tomography, and magnetic resonance imaging) impair their use in areas with a lack of adequately trained cardiologists and technicians. This limitation is likely to hinder the structural heart imaging market growth, especially in emerging markets and smaller healthcare settings having limited expertise.

Structural Heart Imaging Market Opportunities:

• Integration of AI and Machine Learning, Significant Growth Opportunities in the Structural Heart Imaging Market

The use of AI and machine learning in structural heart imaging offers major potential, improving diagnostic accuracy, predictive analytics, and workflow. The firms’ institutions and care centers will gain an edge over competitors when they choose AI-driven imaging, as control over the structural heart imaging market affects profit margins and hastens technology upgrades globally.

For instance, in January 2025Top of Form, Global AI-assisted echocardiography adoption increased 18% in 2024, enhancing diagnostic accuracy and workflow efficiency in structural heart imaging.

Competitive Landscape for Structural Heart Imaging Market:

GE HealthCare is one of the world’s largest suppliers of medical imaging equipment, including 3D/4D echocardiography, cardiac CT, and MRI technology. The company concentrates on embedding AI/machine learning into the cardiac imaging infrastructure to improve diagnostic consistency, increase efficiency in workflow, and improve patient outcomes, and continues to build strong data for powering AI throughout hospitals and heart centers globally.

• In March 2025, GE HealthCare experienced a 12% year-on-year increase in cardiac imaging system sales, driven by the growing adoption of 3D/4D echocardiography and AI-assisted imaging, reflecting strong global demand.

Philips Healthcare is focused on cardiac imaging with 3D/4D echocardiography, cardiac CT, and AI-based imaging systems. The company’s focus is on innovation in non-invasive diagnostics to support transcatheter procedures in the structural heart market, and it has contributed a rich portfolio of tools and devices to facilitate structural heart interventions globally.

• In February 2025, Philips Healthcare’s structural heart imaging revenue grew 15% in 2024, led by increased adoption of cardiac CT and 3D/4D echocardiography in North America and Europe, showcasing expanding market penetration. 

Siemens Healthineers provides a broad range of solutions in cardiovascular imaging, including CT, MRI, echocardiography, and fusion imaging. Their emphasis on the intersection of AI-driven diagnostics, workflow enhancement, and precision guided cardiac interventions uniquely positions them to be a market leader in structural heart imaging in both developed and emerging markets.

• In January 2025, Siemens Healthineers recorded a 10% global increase in structural heart imaging installations, driven by the adoption of cardiac CT and AI-enabled echocardiography, strengthening their market position globally.

Structural Heart Imaging Market Key Players:

Some of the Structural Heart Imaging Market Companies

• GE HealthCare

• Philips Healthcare

• Siemens Healthineers

• Canon Medical Systems

• Hitachi Medical Systems

• Fujifilm Holdings Corporation

• Mindray Medical International

• Samsung Medison

• Neusoft Medical Systems

• Toshiba Medical

• Esaote 

• Edan Instruments

• Chison Medical Technologies

• SonoScape 

• Koninklijke Philips N.V. 

• GE Vivid

• Shimadzu Corporation

• Analogic Corporation

• B-K Medical

• Fukuda Denshi